Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Aug 7;33(2):29.
doi: 10.1007/s40199-025-00572-z.

New psychoactive substances: a multidisciplinary review of challenges and their diverse character

Affiliations
Review

New psychoactive substances: a multidisciplinary review of challenges and their diverse character

Ilinca-Mihaela Marandiuc et al. Daru. .

Abstract

Background: New psychoactive substances (NPS) pose a rapidly evolving public health challenge due to their diverse chemical structures and psychoactive effects, necessitating a comprehensive understanding of their classification, mechanisms of action, and detection.

Objectives: Recognizing critical gaps in the understanding and management of NPS, this review aimed to synthesize current liter-ature. Specifically, we sought to elucidate the evolving classifications of NPS, delineate their underlying molecular mechanisms of action to inform therapeutic strategies, and critically evaluate existing detection methodologies to ad-dress current analytical limitations, thereby providing an essential, integrated perspective on this rapidly changing landscape.

Methods: A narrative literature review was conducted to analyze NPS classification, molecular mechanisms, and detection techniques. Searches were performed across Web of Science, Scopus, PubMed, and Elsevier, using keywords such as "synthetic cathinones", "designer drugs", "new psychoactive substance(s)", "detection of new psychoactive sub-stances" and "toxicology." Inclusion criteria prioritized studies primarily focused on NPS with clearly defined com-pounds (e.g., UNODC, EMCDDA classifications) and published within the last four years. Eligible publications en-compassed in vivo and in vitro studies, original research, and various review types. Exclusion criteria involved liter-ature outside the specified timeframe and studies on established drugs of abuse or licit substances, unless a direct comparative analysis with NPS was presented.

Results: The review synthesized a classification framework for NPS, detailed the molecular mechanisms underlying their psychoactive effects, and summarized current detection methodologies. Furthermore, it underscored the significant health risks associated with NPS use, including addiction, psychological disturbances, organ toxicity, and fatal outcomes.

Conclusion: The continued emergence and proliferation of NPS necessitate ongoing research to fully characterize their specific effects and associated risks. This review provides a foundational synthesis of current knowledge, not only supporting the development of evi-dence-based interventions to mitigate their public health impact, but also serving as a catalyst for new research direc-tions aimed at a deeper understanding and more effective management of these evolving compounds.

Keywords: Designer drugs; Drugs of abuse; New psychoactive substance(s); Risk assessment.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Similar articles

References

    1. Abu Shafi AJ, Berry HS, Wood DM, Tracy DK. New psychoactive substances: a review and updates. Ther Adv Psychopharmacol. 10: 1–21. 10.1177/2045125320967197. - PMC - PubMed
    1. What. are NPS? (unodc.org).
    1. Zang S-YFC-Z, Shih P-H, Ko Y-C, Hsu Y-H, Lin M-C, Tseng S-H, Wang D-Y. A LC-MS/MS method for determination of 73 synthetic Cathinones and related metabolites in urine. Forensic Sci Int 315 (2020) 110429 10.1016/j.forsciint.2020.110429. - PubMed
    1. Vaiano F, Busardo FP, Palumbo D, Kyriakou C, Fioravanti A, Catalani V, Mari F, Bertol E. A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC–MS/MS and application to real cases. J Pharm Biomed Anal. 2016;129:441–9. 10.1016/j.jpba.2016.07.009. - PubMed
    1. European Drug Report. New psychoactive substances– the current situation in Europe (European Drug Report 2023). 2023. www.euda.europa.eu.

MeSH terms

LinkOut - more resources